IL1B and cystic fibrosis: In this regard, in both murine and human CF, NLRP3 activity contributes to IL-1β-dependent inflammation which can be negatively regulated by anakinra, an IL-1 receptor antagonist (IL-1Ra) (McElvaney et al., 2019; Iannitti et al., 2016).